Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Middle Eastern patients with epidermolysis bullosa show specific genetic mutations linked to different types of the disease.

The specific skin disease variant p.(Arg2000Trp) in plectin can cause a wide range of symptoms, which should be considered when diagnosing patients.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Epidermolysis bullosa is a genetic disease causing fragile skin and blisters in both animals and humans.

Combining skin tissue pathology with genetics has greatly improved the diagnosis and understanding of certain skin diseases.

The document concludes that detailed clinical descriptions of seven family cases help understand dominant dystrophic epidermolysis bullosa's symptoms and inheritance.

Platelet-rich plasma is a safe and effective treatment for hair loss, with fewer relapses than steroid treatment.

Natural feedstuffs help reduce muscular dystrophy in rabbits more than selenium or vitamin E alone.

Henna ointment may help reduce itching and improve wound healing in patients with epidermolysis bullosa.

Mutations in the KLHL24 gene cause a skin disorder in some Russian families.

A 37-year-old male with severe skin and internal issues has a rare inherited skin condition called dystrophic epidermolysis bullosa.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Gene and cell therapies are being developed to treat rare skin conditions like epidermolysis bullosa and ichthyosis.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

The conclusion is that self-concept, shame, and emotion regulation are key factors in hoarding disorder, body dysmorphic disorder, and trichotillomania, and should be targeted in treatment and research.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Alopecia areata incognita causes sudden hair thinning, responds well to steroids, and is more common in those with genetic hair loss conditions.

Scalp biopsy and digital phototrichogram help diagnose and manage different types of diffuse hair loss.

PRP therapy is effective for hair regrowth and improving hair quality with minimal side effects.

Skin problems in the elderly are unique and may indicate other diseases, involving changes in skin, hair, nails, and increased cancer risk.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Physical exams are important in hair loss diagnosis, considering cosmetic history, systemic diseases, and classifying alopecia types.

LncRNAs play a crucial role in muscle regulation and could help develop treatments for Duchenne muscular dystrophy.

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

A new mutation, Glu402Lys, in hair keratin is linked to variable symptoms of monilethrix.

Trichoscopy is a tool for detailed examination of hair and scalp diseases.

Localized dystrophic epidermolysis bullosa (DEB) can lead to scarring alopecia, highlighting the need to recognize and address this complication.